Exelixis logo

Senior Clinical Development Medical Director

Exelixis

Alameda, CAOnsitePosted 1 day ago$318,000 - $402,000
Full TimeSenior LevelClinical DevelopmentBiotechnology
Original posting ↗

Summary

In collaboration with the Exelixis clinical teams, the primary role is to lead and execute early/late stage clinical trials for oncology products in development. Participates in the design/planning of clinical studies and helps with the interpretation of study results. Establishes and approves scientific methods for design and implementation of clinical protocols, data collection systems and final reports. May recruit clinical investigators for research studies. Responsibilities also include adverse event reporting and safety responsibilities monitoring. Monitors adherence to protocols and determines study completion.

Job description

Summary/Job Purpose

In collaboration with the Exelixis clinical teams, the primary role is to lead and execute early/late stage clinical trials for oncology products in development. Participates in the design/planning of clinical studies and helps with the interpretation of study results. Establishes and approves scientific methods for design and implementation of clinical protocols, data collection systems and final reports. May recruit clinical investigators for research studies. Responsibilities also include adverse event reporting and safety responsibilities monitoring. Monitors adherence to protocols and determines study completion.

Essential Duties and Responsibilities

  • Design, prepare and initiate study protocols and other required documentation in compliance with project plans, federal regulations, GCP and good medical practice.
  • Act as medical monitor for company sponsored trials.
  • Support project teams with therapeutic area specific information.
  • Collaborate with internal safety group in analyzing and reporting of safety data from clinical trials.
  • Analyze and interpret other clinical trial data and prepare reports for regulatory agencies and publication.
  • Interact with key opinion leaders and investigators in relevant disease specific area.
  • Ensure consistency of scientific and development strategies for oncology products in development.
  • Maintain the highest level of scientific and clinical knowledge in relevant disease specific area.

Supervisory Responsibilities

  • None
  • May on case-by-case basis supervise employees, both directly and indirectly through a dotted line structure or via other subordinate supervisors.

Education/Experience

  • MD (board certification or eligibility in Oncology or Hematology/Oncology desirable but not essential) required with a minimum of 8 years of post-residency experience.
  • Equivalent combination of education and experience

Experience/The Ideal for Successful Entry into Job

  • Drug development experience in biotechnology or pharmaceutical industry, or a combination of academia and industry. Note: Individuals with extensive academic experience but without experience in the pharmaceutical industry may be considered
  • Hands-on experience in the design, execution, and reporting of controlled clinical trials in oncology.
  • Participated in clinical oncology studies with molecular targeted or immunological therapies.
  • Understanding of basic science relevant to clinical oncology (biochemistry, immunology, molecular biology and/or genetics).

Knowledge/Skills

  • Proven ability to effectively work in a cross-functional/matrix environment
  • Uses broad expertise or unique knowledge and skills to contribute to development of company objectives and principles and to achieve goals in creative and effective ways.
  • Develops technical and/or business solutions to complex problems.
  • Identifies and implements methods, techniques, procedures and evaluation criteria to achieve results.
  • Ability to develop and maintain relationships with significant key opinion leaders.
  • Strong interpersonal, influencing, presentation, and written and verbal communication skills
  • Strong organizational and time management skills

Job Complexity

  • Works on complex problems where analysis of situations or data requires an in-depth evaluation of various factors
  • Works on abstract problems across functional areas of the business
  • Exercises independent judgment in methods, techniques and evaluation of criteria for obtaining results.
  • Regularly interacts with executives and/or major customers.

Requirements

  • MD required
  • Board certification or eligibility in Oncology or Hematology/Oncology desirable but not essential
  • Minimum of 8 years of post-residency experience
  • Drug development experience in biotechnology or pharmaceutical industry, or combination of academia and industry
  • Hands-on experience in design, execution, and reporting of controlled clinical trials in oncology
  • Participated in clinical oncology studies with molecular targeted or immunological therapies
  • Understanding of basic science relevant to clinical oncology (biochemistry, immunology, molecular biology and/or genetics)
  • Proven ability to effectively work in a cross-functional/matrix environment
  • Ability to develop and maintain relationships with significant key opinion leaders
  • Strong interpersonal, influencing, presentation, and written and verbal communication skills
  • Strong organizational and time management skills

Benefits

  • 401(k) Matching
  • Medical, Dental & Vision
  • Life & Disability Insurance
  • Flexible Spending Accounts
  • Discretionary Annual Bonus
  • Company Stock Purchase
  • Long-Term Incentives
  • 15 Vacation Days
  • 17 Paid Holidays
  • Up to 10 Sick Days

Company overview

Exelixis, Inc. is an oncology-focused biotechnology company headquartered in Alameda, California, that specializes in the discovery, development, and commercialization of innovative cancer treatments. Founded in 1994, the company has evolved into a multi-platform cancer organization with a proven track record in the challenging biotech sector. Exelixis is best known for its flagship molecule cabozantinib, an inhibitor of multiple tyrosine kinases including MET, AXL, VEGF receptors, and RET, which has led to several approved drugs for difficult-to-treat cancers. The company's portfolio includes four approved drugs, with two derived from cabozantinib, and it maintains a robust pipeline of next-generation cancer treatments. With approximately 1,500 employees across five continents, Exelixis operates as a publicly traded company (NASDAQ: EXEL) and has established strategic alliances with major pharmaceutical and biotechnology partners. The company's mission centers on transforming science into new treatments that give cancer patients and their families hope for the future, with every employee united in this ambitious cause.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.